Innovation and evaluation of surgery in research

Loading

Innovation and evaluation of surgery in research

10 Nov 2021
Theatre 1
Working Better

In this session we’ll discuss evaluation of innovation in surgery. We’ll hear from the lead authors of two trials published in The Lancet this year “Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy” and “Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial”. You’ll hear from the authors, Richard Bulbulia, Geltrude Mingrone and Francesco Rubino respectively, about the trial design, barriers they faced and lessons learnt followed by a panel discussion and open Q&A to explore how we evaluate innovation chaired by Jessamy Bagenal from The Lancet.

Chairperson
Jessamy Baganel - THE LANCET
Speakers
Francesco Rubino, Chair of Metabolic and Bariatric Surgery - King's College London
Geltrude Mingrone, Professor of Diabetes and Nutrition - King’s College London
Richard Bulbulia, Consultant Vascular Surgeon & Senior Research Fellow - MRC Population Health Research Unit and Clinical Trial Service Unit, University of Oxford
  • “Future Surgery 2021 will be the first of its kind in the UK, drawing on the work our Commission on the Future of Surgery has done to predict the transformation in the medical care for millions of patients.”
    Andrew Reed, Chief Executive of the Royal College of Surgeons of England
  • “Driven by changes in digital technologies and our fast-evolving understanding of genomics, innovations are expected to affect how we undertake surgery, and how we train surgeons in future.”
    Andrew Reed, Chief Executive of the Royal College of Surgeons of England
  • "Alongside the conference organisers, CloserStill, we aim to deliver a high-quality event that will provide both professional development and discussion space for surgeons and their teams."
    Andrew Reed, Chief Executive of the Royal College of Surgeons of England
  • "We look forward to welcoming colleagues to what promises to be a very high-quality programme and an exciting two days of thought-provoking training and engagement with medical suppliers."
    Andrew Reed, Chief Executive of the Royal College of Surgeons of England

EVENT PARTNER


 

PLATINUM SPONSOR

Edinurgh

PLATINUM SPONSOR

CMR

PLATINUM SPONSOR

quilter

GOLD SPONSOR


 

GOLD SPONSOR


 

GOLD SPONSOR

Sony

Sustainability Sponsor

SPONSOR

AneticAid

SPONSOR


 

SPONSOR


 

SPONSOR

Creed Medical

SPONSOR

Corza Medical

SPONSOR


 

SPONSOR

Epiqar

SPONSOR

Fundamental Surgery

SPONSOR


 

SPONSOR

Intuitive

SPONSOR


 

SPONSOR


 

SPONSOR


 

SPONSOR


 

SPONSOR


 

SPONSOR

  • Open Medical

 

SPONSOR

  • 365 Healthcare

 

Event Supporter


 

Event Supporter


 

Event Supporter


 

Event Supporter

British Orthopaedic Association

Event Supporter


 

Event Supporter


 

Event Supporter


 

Event Supporter


 

Event Supporter

SSSIM

MEDIA PARTNER

CSJ

MEDIA PARTNER

Operating Theatre Journal